Frank Besag

7.1k total citations
119 papers, 4.5k citations indexed

About

Frank Besag is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cognitive Neuroscience. According to data from OpenAlex, Frank Besag has authored 119 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Psychiatry and Mental health, 57 papers in Pediatrics, Perinatology and Child Health and 21 papers in Cognitive Neuroscience. Recurrent topics in Frank Besag's work include Epilepsy research and treatment (69 papers), Pharmacological Effects and Toxicity Studies (46 papers) and Genetics and Neurodevelopmental Disorders (17 papers). Frank Besag is often cited by papers focused on Epilepsy research and treatment (69 papers), Pharmacological Effects and Toxicity Studies (46 papers) and Genetics and Neurodevelopmental Disorders (17 papers). Frank Besag collaborates with scholars based in United Kingdom, United States and Hong Kong. Frank Besag's co-authors include Michael J. Vasey, Ian Chi Kei Wong, Rod C. Scott, Brian G.R. Neville, David J. Berry, Albert P. Aldenkamp, Macey L. Murray, Martin J. Brodie, Felicity Jane Pool and Rochelle Caplan and has published in prestigious journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Frank Besag

116 papers receiving 4.3k citations

Peers

Frank Besag
Cynthia L. Harden United States
Raj D. Sheth United States
G Hagberg Sweden
Francesco Monaco Italy
Sanjeev V. Kothare United States
Sheryl R. Haut United States
Maria Paola Canevini Italy
Peter Camfield Canada
Brian G.R. Neville United Kingdom
Richard Chin United Kingdom
Cynthia L. Harden United States
Frank Besag
Citations per year, relative to Frank Besag Frank Besag (= 1×) peers Cynthia L. Harden

Countries citing papers authored by Frank Besag

Since Specialization
Citations

This map shows the geographic impact of Frank Besag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Besag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Besag more than expected).

Fields of papers citing papers by Frank Besag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Besag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Besag. The network helps show where Frank Besag may publish in the future.

Co-authorship network of co-authors of Frank Besag

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Besag. A scholar is included among the top collaborators of Frank Besag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Besag. Frank Besag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, Adrienne Y L, Yingfen Hsia, Wallis C. Y. Lau, et al.. (2025). Antiseizure medications consumption in 73 countries and regions from 2012 to 2022: a longitudinal trend study. EClinicalMedicine. 89. 103558–103558.
2.
Besag, Frank, Michael J. Vasey, & Richard Chin. (2025). Recent Advances in the Management of Seizures in Children. Pediatric Drugs. 28(1). 43–68.
3.
Chan, Adrienne Y L, Daniel Hsiang‐Te Tsai, Wallis C. Y. Lau, et al.. (2023). Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend study. Nature Communications. 14(1). 5005–5005. 29 indexed citations
4.
Besag, Frank, Michael J. Vasey, & Arjune Sen. (2023). Current evidence for adjunct pyridoxine (vitamin B6) for the treatment of behavioral adverse effects associated with levetiracetam: A systematic review. Epilepsy & Behavior. 140. 109065–109065. 3 indexed citations
5.
Besag, Frank, Le Gao, Tiantian Ma, et al.. (2021). Antipsychotic Medication and Risk of Incident Seizure in People with Autism Spectrum Disorder: Analyses with Cohort and Within Individual Study Designs. Journal of Autism and Developmental Disorders. 52(11). 4817–4827. 1 indexed citations
6.
Man, Kenneth K. C., et al.. (2019). Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK. Journal of Autism and Developmental Disorders. 50(2). 625–633. 19 indexed citations
7.
8.
Dunn, David W., Frank Besag, Rochelle Caplan, et al.. (2016). Psychiatric and Behavioural Disorders in Children with Epilepsy (ILAE Task Force Report): Anxiety, depression and childhood epilepsy. Epileptic Disorders. 18(s1). 35 indexed citations
9.
10.
Besag, Frank. (2014). ADHD Treatment and Pregnancy. Drug Safety. 37(6). 397–408. 17 indexed citations
11.
Piedad, John, Hugh Rickards, Frank Besag, & Andrea E. Cavanna. (2012). Beneficial and Adverse Psychotropic Effects of Antiepileptic Drugs in Patients with Epilepsy. CNS Drugs. 26(4). 319–335. 101 indexed citations
12.
Iessa, Noha, Kristina Star, Lynda Wilton, et al.. (2011). Montelukast and Suicide: Causality Assessment Using Spontaneous Reports and Bradford Hill Guidelines. Drug Safety. 34. 949–950. 2 indexed citations
13.
Trimble, Michael, Albert P. Aldenkamp, Dale C. Hesdorffer, et al.. (2011). The Neuropsychiatry of Epilepsy. Cambridge University Press eBooks. 29 indexed citations
14.
Besag, Frank, et al.. (2001). Safety, tolerability, and pharmacokinetics of remacemide in children. Pediatric Neurology. 24(5). 352–356. 2 indexed citations
15.
Besag, Frank. (2000). Is Generic Prescribing Acceptable in Epilepsy?. Drug Safety. 23(3). 173–182. 46 indexed citations
16.
Guberman, A., Frank Besag, Martin J. Brodie, et al.. (1999). Lamotrigine‐Associated Rash: Risk/Benefit Considerations in Adults and Children. Epilepsia. 40(7). 985–991. 253 indexed citations
17.
Besag, Frank, Olivier Dulac, Jørgen Alving, & E.L. Mullens. (1997). Long-term safety and efficacy of lamotrigine (Lamictal®) in paediatric patients with epilepsy. Seizure. 6(1). 51–56. 43 indexed citations
18.
Marston, D., et al.. (1993). EFFECTS OF TRANSITORY COGNITIVE IMPAIRMENT ON PSYCHOSOCIAL FUNCTIONING OF CHILDREN WITH EPILEPSY: A THERAPEUTIC TRIAL. Developmental Medicine & Child Neurology. 35(7). 574–581. 87 indexed citations
19.
Larkin, John G., Frank Besag, A. Cox, John A. Williams, & Martin J. Brodie. (1992). Nifedipine for Epilepsy? A Double‐Blind, Placebo‐Controlled Trial. Epilepsia. 33(2). 346–352. 27 indexed citations
20.
Besag, Frank, et al.. (1989). The validation of a new ambulatory spike and wave monitor. Electroencephalography and Clinical Neurophysiology. 73(2). 157–161. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cynthia L. Harden Breakdown of academic impact, for papers by Raj D. Sheth Breakdown of academic impact, for papers by G Hagberg Breakdown of academic impact, for papers by Francesco Monaco Breakdown of academic impact, for papers by Sanjeev V. Kothare Breakdown of academic impact, for papers by Sheryl R. Haut Breakdown of academic impact, for papers by Maria Paola Canevini Breakdown of academic impact, for papers by Peter Camfield Breakdown of academic impact, for papers by Brian G.R. Neville Breakdown of academic impact, for papers by Richard Chin
Rankless by CCL
2026